Winton Group’s Integra LifeSciences IART Stock Holding History

Winton Group’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.84M	Buy	+102,632	New	+$1.44M	0.06%	310
2026 Q1	–	Sell	-68,867	Closed	-$855K	–	1242
2025 Q4	$855K	Sell	68,867 -2,932	-4%	-$39K	0.03%	513
2025 Q3	$1.03M	Sell	71,799 -65,754	-48%	-$901K	0.04%	450
2025 Q2	$1.69M	Sell	137,553 -11,402	-8%	-$166K	0.09%	279
2025 Q1	$3.28M	Buy	+148,955	New	+$3.5M	0.2%	124
2022 Q4	–	Sell	-9,971	Closed	-$422K	–	978
2022 Q3	$422K	Buy	9,971 +5,250	+111%	+$269K	0.03%	689
2022 Q2	$255K	Buy	+4,721	New	+$284K	0.01%	841
2021 Q1	–	Sell	-9,142	Closed	-$593K	–	1405
2020 Q4	$593K	Buy	9,142 +2,029	+29%	+$109K	0.04%	699
2020 Q3	$336K	Buy	+7,113	New	+$338K	0.01%	1212
2018 Q3	–	Sell	-180,258	Closed	-$11.6M	–	1055
2018 Q2	$11.6M	Buy	180,258 +162,907	+939%	+$10.1M	0.3%	93
2018 Q1	$960K	Buy	+17,351	New	+$909K	0.03%	517
2017 Q2	–	Sell	-13,654	Closed	-$575K	–	614
2017 Q1	$575K	Buy	13,654 +4,822	+55%	+$206K	0.02%	364
2016 Q4	$379K	Buy	+8,832	New	+$359K	0.01%	391

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Winton Group's IART Position: Q2 2026 in Review

Winton Group opened a new position in Integra LifeSciences (IART) in Q2 2026: 102,632 shares worth $1.84M. The stake represents 0.06% of the portfolio and ranks #310 among its holdings. This is a return to the name: Winton Group previously reported a position in IART as recently as Q4 2025.

Winton Group first reported a position in IART in Q4 2016 and has held it in 13 quarters since. The position peaked at $11.6M in Q2 2018. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

Winton Group held 102,632 shares of Integra LifeSciences worth $1.84M as of Q2 2026.
Integra LifeSciences was a new Winton Group position in Q2 2026.
Integra LifeSciences made up 0.06% of Winton Group's portfolio in Q2 2026, its #310 holding.
Winton Group first reported a position in Integra LifeSciences in Q4 2016 and has held it in 13 quarters since.
Winton Group's Integra LifeSciences position peaked at $11.6M in Q2 2018.
212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.